A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis

Condition:   Seasonal Allergic Rhinitis Interventions:   Drug: Fexofenadine;   Drug: Placebo Sponsor:   Opella Healthcare Group SAS, a Sanofi Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials